MedTrace Logo

Observational Study in Participants With Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM) and Non-Hodgkin's Lymphoma (NHL) in Latin America

NCT02559583 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5443

Last updated 2016-07-20

No results posted yet for this study

Summary

The primary purpose of the study is to quantify participants' demographic parameters, country standard therapies, treatment patterns and outcomes among participants with chronic lymphocytic leukemia (CLL), multiple myeloma (MM) and non-Hodgkin's lymphoma (NHL) in oncology concentration hospitals in Latin America.

Conditions

Interventions

OTHER

Chronic Lymphocytic Leukemia (CLL)

This is observational study. Participants with Chronic Lymphocytic Leukemia (CLL) will be observed for 1 year.

OTHER

Multiple Myeloma (MM)

This is observational study. Participants with Multiple Myeloma (MM) will be observed for 1 year.

OTHER

Non-Hodgkin's lymphoma (NHL)

This is observational study. Participants with non-Hodgkin's lymphoma (NHL) will be observed for 1 year.

Sponsors & Collaborators

  • Janssen-Cilag Ltd.

    lead INDUSTRY

Principal Investigators

  • Janssen-Cilag Ltd. Clinical Trial · Janssen-Cilag Ltd.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • Argentina
  • Brazil
  • Chile
  • Colombia
  • Guatemala
  • Mexico
  • Panama

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02559583 on ClinicalTrials.gov